R Garg, E Angus, S Fincher. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antimetabolites, Antineoplastic/adverse effectsBlood Glucose/analysisCapecitabineColonic Neoplasms/drug therapyDeoxycytidine/adverse effectsDeoxycytidine/analogs & derivativesFenofibrate/analogs & derivativesFenofibrate/therapeutic useFluorouracil/adverse effectsFluorouracil/analogs & derivativesGlycated Hemoglobin A/analysisHumansHypertriglyceridemia/chemically inducedHypolipidemic Agents/therapeutic useLipids/bloodMaleMiddle AgedTreatment Outcome
Substances: See more » Antimetabolites, AntineoplasticBlood GlucoseGlycated Hemoglobin AHypolipidemic AgentsLipidsDeoxycytidineCapecitabinefenofibric acidFenofibrateFluorouracil
Year: 2009 PMID: 20002489 DOI: 10.1111/j.1464-5491.2009.02842.x
Source DB: PubMed Journal: Diabet Med ISSN: 0742-3071 Impact factor: 4.359